Clinical features of nonalcoholic steatohepatitis in Japan : evidence from the literature

作者: Masafumi Ono , Toshiji Saibara

DOI: 10.1007/S00535-006-1876-0

关键词:

摘要: Metabolic syndrome, that is, obesity, hypertension, hyperlipidemia, and insulin resistance with hyperinsulinemia, is a new disease entity prevailing worldwide, nonalcoholic steatohepatitis (NASH) believed to be hepatic expression of this syndrome. NASH characterized by zone 3-dominant steatosis ballooned hepatocytes Mallory bodies, 3 pericellular perivenular fibrosis or without bridging fibrosis, lobular inflammatory cell infiltration. Indeed, 90% has been revealed complicated visceral two-thirds patients fulfill the criteria metabolic Therefore, variety lifestyle-related diseases such as diabetes mellitus may share same background. most prevalent well in Caucasians; however, little known about its occurrence Asia-Oceania, because obesity not frequent countries these areas. Obesity expected become serious social problem Asia-Oceania next two decades, so we need prevent corresponding increase NASH. For purpose, know much only but also ourselves. To elucidate status Japan, recent progress study Japan reviewed article.

参考文章(95)
Dongsheng Cai, Minsheng Yuan, Daniel F Frantz, Peter A Melendez, Lone Hansen, Jongsoon Lee, Steven E Shoelson, Local and systemic insulin resistance resulting from hepatic activation of IKK-β and NF-κB Nature Medicine. ,vol. 11, pp. 183- 190 ,(2005) , 10.1038/NM1166
Steven H. Zeisel, Kerry‐Ann Da Costa, Peter D. Franklin, Edward A. Alexander, J. Thomas Lamont, Nancy F. Sheard, Alexa Beiser, Choline, an essential nutrient for humans. The FASEB Journal. ,vol. 5, pp. 2093- 2098 ,(1991) , 10.1096/FASEBJ.5.7.2010061
Mika Yoshimatsu, Yasuhiro Terasaki, Naomi Sakashita, Emi Kiyota, Hiroo Sato, Luc J. W. Van Der Laan, Motohiro Takeya, Induction of macrophage scavenger receptor MARCO in nonalcoholic steatohepatitis indicates possible involvement of endotoxin in its pathogenic process International Journal of Experimental Pathology. ,vol. 85, pp. 335- 343 ,(2004) , 10.1111/J.0959-9673.2004.00401.X
Toshiji Saibara, Can an increase of body mass index by 1 kg/m(2) be a risk for obesity-related diseases? Journal of Gastroenterology. ,vol. 38, pp. 1022- 1023 ,(2003) , 10.1007/S00535-003-1209-5
Motoyuki Kohjima, Munechika Enjoji, Nobito Higuchi, Masaki Kato, Kazuhiro Kotoh, Tsuyoshi Yoshimoto, Tatsuya Fujino, Masayoshi Yada, Ryoko Yada, Naohiko Harada, Ryoichi Takayanagi, Makoto Nakamuta, Re-evaluation of fatty acid metabolism-related gene expression in nonalcoholic fatty liver disease International Journal of Molecular Medicine. ,vol. 20, pp. 351- 358 ,(2007) , 10.3892/IJMM.20.3.351
Chisato Murata, Tetsu Watanabe, Hiroyuki Furuya, Yoshihiko Sugioka, Hajime Mikurube, Akira Yokoyama, Yoshihito Atsumi, Kempei Matsuoka, Isao Okazaki, Aldehyde dehydrogenase 2 and β3-Adrenergic receptor gene polymorphisms: Their association with elevated liver enzymes and metabolic syndrome Metabolism-clinical and Experimental. ,vol. 52, pp. 1096- 1101 ,(2003) , 10.1016/S0026-0495(03)00183-5
T. Kadowaki, Y. Miyake, R. Hagura, Y. Akanuma, H. Kajinuma, N. Kuzuya, F. Takaku, K. Kosaka, Risk factors for worsening to diabetes in subjects with impaired glucose tolerance Diabetologia. ,vol. 26, pp. 44- 49 ,(1984) , 10.1007/BF00252262